Name | Number of supported studies | Average coverage | |
---|---|---|---|
GABAergic neuron | 3 studies | 22% ± 5% | |
astrocyte | 3 studies | 19% ± 4% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 4 studies | 18% ± 3% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
bladder | 100% | 2859.14 | 21 / 21 | 100% | 17.03 | 504 / 504 |
breast | 100% | 2502.12 | 459 / 459 | 100% | 21.37 | 1118 / 1118 |
esophagus | 100% | 2404.77 | 1445 / 1445 | 100% | 18.70 | 183 / 183 |
prostate | 100% | 2874.49 | 245 / 245 | 100% | 16.14 | 502 / 502 |
stomach | 100% | 1838.50 | 359 / 359 | 100% | 14.18 | 286 / 286 |
lung | 100% | 2092.39 | 578 / 578 | 100% | 18.78 | 1153 / 1155 |
skin | 100% | 3095.02 | 1809 / 1809 | 100% | 16.42 | 471 / 472 |
uterus | 100% | 2934.08 | 170 / 170 | 100% | 18.27 | 458 / 459 |
intestine | 100% | 2433.25 | 966 / 966 | 100% | 14.63 | 525 / 527 |
ovary | 100% | 2821.15 | 180 / 180 | 100% | 10.90 | 428 / 430 |
pancreas | 100% | 1596.10 | 328 / 328 | 99% | 14.52 | 177 / 178 |
thymus | 100% | 2371.32 | 653 / 653 | 99% | 11.79 | 599 / 605 |
brain | 99% | 1399.49 | 2625 / 2642 | 99% | 14.80 | 700 / 705 |
kidney | 100% | 1699.93 | 89 / 89 | 98% | 10.39 | 879 / 901 |
liver | 100% | 1561.47 | 226 / 226 | 96% | 10.32 | 391 / 406 |
adrenal gland | 100% | 1795.56 | 258 / 258 | 93% | 8.39 | 215 / 230 |
adipose | 100% | 2101.49 | 1204 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 2947.62 | 1335 / 1335 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 100% | 13.32 | 29 / 29 |
muscle | 100% | 2490.32 | 803 / 803 | 0% | 0 | 0 / 0 |
spleen | 100% | 2340.56 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 17.33 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 9.94 | 1 / 1 |
heart | 99% | 1541.79 | 852 / 861 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 99% | 13.90 | 79 / 80 |
peripheral blood | 84% | 1007.82 | 783 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0045814 | Biological process | negative regulation of gene expression, epigenetic |
GO_0045869 | Biological process | negative regulation of single stranded viral RNA replication via double stranded DNA intermediate |
GO_0090309 | Biological process | positive regulation of DNA methylation-dependent heterochromatin formation |
GO_0006974 | Biological process | DNA damage response |
GO_0006631 | Biological process | fatty acid metabolic process |
GO_0006338 | Biological process | chromatin remodeling |
GO_0000792 | Cellular component | heterochromatin |
GO_0005654 | Cellular component | nucleoplasm |
GO_0016363 | Cellular component | nuclear matrix |
GO_0005829 | Cellular component | cytosol |
GO_0005737 | Cellular component | cytoplasm |
GO_0005634 | Cellular component | nucleus |
GO_0042803 | Molecular function | protein homodimerization activity |
GO_0003682 | Molecular function | chromatin binding |
GO_0000287 | Molecular function | magnesium ion binding |
GO_0008270 | Molecular function | zinc ion binding |
GO_0005524 | Molecular function | ATP binding |
GO_0005515 | Molecular function | protein binding |
GO_0016887 | Molecular function | ATP hydrolysis activity |
Gene name | MORC2 |
Protein name | MORC family CW-type zinc finger 2 ATPase MORC2 (EC 3.6.1.-) (MORC family CW-type zinc finger protein 2) (Zinc finger CW-type coiled-coil domain protein 1) |
Synonyms | KIAA0852 ZCWCC1 |
Description | FUNCTION: Essential for epigenetic silencing by the HUSH (human silencing hub) complex. Recruited by HUSH to target site in heterochromatin, the ATPase activity and homodimerization are critical for HUSH-mediated silencing . Represses germ cell-related genes and L1 retrotransposons in collaboration with SETDB1 and the HUSH complex, the silencing is dependent of repressive epigenetic modifications, such as H3K9me3 mark. Silencing events often occur within introns of transcriptionally active genes, and lead to the down-regulation of host gene expression . During DNA damage response, regulates chromatin remodeling through ATP hydrolysis. Upon DNA damage, is phosphorylated by PAK1, both colocalize to chromatin and induce H2AX expression. ATPase activity is required and dependent of phosphorylation by PAK1 and presence of DNA . Recruits histone deacetylases, such as HDAC4, to promoter regions, causing local histone H3 deacetylation and transcriptional repression of genes such as CA9 . Exhibits a cytosolic function in lipogenesis, adipogenic differentiation, and lipid homeostasis by increasing the activity of ACLY, possibly preventing its dephosphorylation . . |
Accessions | Q9Y6X9 ENST00000215862.8 [Q9Y6X9-2] H7C1V1 ENST00000397641.8 [Q9Y6X9-1] ENST00000675779.1 A0A6Q8PGC6 ENST00000445980.5 A0A6Q8PHH3 ENST00000675570.1 |